News
2025 in a glance
The year 2025 has been an impactful one for the African Genetic Biocontrol Consortium (AGBC). We wish to extend our appreciation to all our members, partners, supporters and stakeholders across Africa and beyond. Here are the highlights of key milestones executed in 2025. The Second Global Congress on New and Emerging Genetic Biocontrol Technologies is […]
COP 15 Side Event: Capacity Strengthening for Risk Assessment of New Biotechnologies in Africa – Building on Experiences with Genetic Biocontrol Posted on December 16 2022
On 9th December 2022, the African Genetic Biocontrol Consortium in collaboration with GeneConvene Global Collaborative at the Foundation for the National Institutes of Health (FNIH) USA held a side event during the Fifteenth meeting of the Conference of the Parties (COP 15) in Montreal, Canada. The focus of this side event was on new and emerging technologies, which include advances in the fields of synthetic biology and biotechnology, have led to the development of a wide range of proposed applications of their resulting outputs. Some of these applications are in line with the UN Sustainable Goal, SDG-3 that ensures healthy living and promotes well-being for all at all ages. Read more
AFRICAN GENETIC BIOCONTROL CONSORTIUM HOLDS A TRAINING WORKSHOP ON NEW TOOLS FOR RISK ASSESSMENT AND THEIR APPLICATION IN DECISION-MAKING PROCESS FOR TESTING AND DEPLOYMENT OF NEW AND EMERGING GENETIC BIOCONTROL TECHNOLOGIES Posted on July 29, 2022
During a training workshop held from 16th to 18th July in Nairobi, Kenya, participants who were a select group of African biosafety regulators were taken through an introduction to risk assessment and associated methods (qualitative and quantitative), in the context of genetic bio-control. Read more
Genetically altered mosquitoes to close gaps in malaria fight Monday, April 25 , 2022
In 2020, nearly 6.9 million cases of malaria and about 742 deaths were confirmed in Kenya according to the Kenya Malaria Indicator Survey (KMIS) 2020. Although the number of reported infections declined from 10.9 million in 2018, the disease is still one of the main health issues in the country despite being a largely preventable and treatable disease…Read more